Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate CancerPhilip W. Kantoff, Wayne R. Godfrey, Kelledy Manson et al.|Journal of Clinical Oncology|2010Cited by 973
Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate CancerSusan Halabi, Nicholas J. Vogelzang, Eric J. Small et al.|Journal of Clinical Oncology|2003Cited by 678
A Clinical Development Paradigm for Cancer Vaccines and Related BiologicsAxel Hoos, Geoffrey Nichol, Ulrich Keilholz et al.|Journal of Immunotherapy|2006Cited by 271